December 24th, 2011 by BarbaraFederOstrov in Health Policy, News
No Comments »
Kim Jong Il: Of course we’re going to highlight the lowlights of the North Korean leader’s health: CNN has the scoop on the dictator’s cause of death and previous illnesses. Knight Science Journalism Tracker’s Paul Raeburn rounds up previous analyses of Kim Jong Il’s psychological profile.
Breast Cancer: Companies are trying to build a better mammogram as they compete for a bigger slice of the $6 billion-and-growing medical imaging market, Sierra Jiminez reports for Fortune. Nearly 300,000 American women have been diagnosed with breast cancer this year.
Health Reform: The U.S. Supreme Court will devote an unprecedented week of oral argument over health reform when Read more »
*This blog post was originally published at Reporting on Health - The Reporting on Health Daily Briefing*
August 21st, 2011 by GarySchwitzer in News, Opinion
No Comments »
Right off the top, let me be clear that I am NOT minimizing the importance of this week’s news about an experimental treatment for leukemia – one that has drawn much news attention.
It is an important finding.
What I am commenting on herein is the news coverage.
The ABC television piece itself wasn’t bad, with good perspective from Dr. Len Lichtenfeld of the American Cancer Society. But the lead-in and the ending, both involving anchor Diane Sawyer, were hyperbolic. The following screenshot was part of Sawyer’s lead-in. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
October 5th, 2010 by GarySchwitzer in Better Health Network, Health Policy, Health Tips, News, Opinion, Research, Video
No Comments »
We reviewed four stories on the Swedish mammography study that appeared in the journal Cancer last week. Three of the four stories gave a pretty clear indication that there were methodological concerns about the Swedish research (of the four reviewed, only HealthDay offered no such hint):
• 4th paragraph of AP story: “The new study has major limitations and cannot account for possibly big differences in the groups of women it compares.”
• 1st paragraph of LA Times blog story: “Critics charged that the study was poorly designed and potentially vastly misleading.”
• 2nd sentence of NY Times story: “Results were greeted with skepticism by some experts who say they may have overestimated the benefit.”
But none of the stories did a very complete job of explaining those potential limitations. Because of the confusion that must be occurring in the minds of women — especially those in their 40s — this is a time in which journalism must rise to the need and do a better job of evaluating evidence and helping readers make sense of what appear to be conflicting findings.
I was in Chapel Hill, North Carolina, when the study was published and had the chance to talk about it with former U.S. Preventive Services Task Force member, and a recognized thought leader on issues of prevention and especially of screening tests, Dr. Russell Harris, Professor and Director of the Health Care and Prevention Concentration of the University of North Carolina (UNC) School of Public Health. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
September 8th, 2010 by GarySchwitzer in Better Health Network, Health Policy, Health Tips, News, Opinion, Research
No Comments »
Journalist Andrew Holtz has been a colleague for longer than probably either one of us wants to remember. He is currently one of our story reviewers on HealthNewsReview.org. In fact, he was one of the reviewers on four stories we analyzed last week on the same study. He thought there were some important take-home messages that rose above the walls of our formal systematic review, so he wrote this guest blog post, and we thank him for it:
The Sept. 1 issue of the Journal of the American Medical Association included an article that is likely to have a strong influence on the advice given to women who have a very high risk of breast and ovarian cancer linked to mutations of the BRCA1 and BRCA2 genes. Of the four stories we reviewed, only the AP report scored well on our review criteria.
I know what my first journalism professor, Marion Lewenstein, would have done with at least two of the stories: Given them an “F” for factual errors without further consideration of their merits. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
Distracted Driving: Studies of 
